Vale SA (ADR) (NYSE:VALE), the world’s No.1 iron ore producer, received a $2.8 billion loan from the country’s national development bank BNDES for expansions at Carajas, the largest iron-ore complex in the world. Vale SA (ADR) (NYSE:VALE) shares after opening at $14.24 moved to $14.25 on last trade day and at the end of the day closed at $13.90. Company price to sales ratio in past twelve months was calculated as 1.50 and price to cash ratio as 10.05. Vale SA (ADR) (NYSE:VALE) showed a negative weekly performance of -7.76%.
Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) had presentations at the 2014 American Association for Cancer Research (AACR) Annual Meeting. The conference was held in San Diego, California, on April 5-9, 2014 at the San Diego Convention Center. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) shares fell -7.75% in last trading session and ended the day on $0.932. RNN return on equity ratio is recorded as -81.70% and its return on assets is -49.00%. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) yearly performance is 210.57%.
Oi SA (ADR) (NYSE:OIBR) dipped by falling to a new 52 week low as the Brazilian stocks fell due to rise in Dollar on Monday and the outlook for inflation in Latin America’s biggest economy worsened. Oi SA (ADR) (NYSE:OIBR) shares moved down -8.73% in last trading session and was closed at $1.15 while trading in range of $1.14 – $1.26 – Oi SA (ADR) (NYSE:OIBR) year to date (YTD) performance is -27.67%.
Shares of National Bank of Greece SA (ADR) (NYSE:NBG) declined nearly 15% on Apr 14 after a Reuters report stated that the company was planning to raise additional capital by issuing shares. Headquartered in Athens, Greece, the bank will be issuing roughly €2.2 billion ($3.03 billion) worth of shares to plug in its capital deficit, though the final decision will be taken by its board of directors. National Bank of Greece (ADR) (NYSE:NBG) weekly performance is -23.32%. On last trading day company shares ended up $4.21. National Bank of Greece (ADR) (NYSE:NBG) distance from 50-day simple moving average (SMA50) is -17.76%. Analysts mean target price for the company is $5.71.